Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Prognostic Significance of Preoperative Lymphocyte-Monocyte Ratio in Patients with Resectable Esophageal Squamous Cell Carcinoma

  • Han, Li-Hui (Department of Radiation Oncology, Qilu Hospital of Shandong University) ;
  • Jia, Yi-Bin (Department of Radiation Oncology, Qilu Hospital of Shandong University) ;
  • Song, Qing-Xu (Department of Radiation Oncology, Qilu Hospital of Shandong University) ;
  • Wang, Jian-Bo (Department of Radiation Oncology, Qilu Hospital of Shandong University) ;
  • Wang, Na-Na (Department of Radiation Oncology, Qilu Hospital of Shandong University) ;
  • Cheng, Yu-Feng (Department of Radiation Oncology, Qilu Hospital of Shandong University)
  • Published : 2015.04.03
Download PDF
⟨ Previous Next ⟩

Abstract

Background: The interaction between tumor cells and inflammatory cells has not been systematically investigated in esophageal squamous cell carcinoma (ESCC). The aim of the present study was to evaluate whether preoperative the lymphocyte-monocyte ratio (LMR), the neutrophil-lymphocyte ratio (NLR), and the platelet-lymphocyte ratio (PLR) could predict the prognosis of ESCC patients undergoing esophagectomy. Materials and Methods: Records from 218 patients with histologically diagnosed ESCC who underwent attempted curative surgery from January 2007 to December 2008 were retrospectively reviewed. Besides clinicopathological prognostic factors, we evaluated the prognostic value of the LMR, the NLR, and the PLR using Kaplan-Meier curves and Cox regression models. Results: The median follow-up was 38.6 months (range 3-71 months). The cut-off values of 2.57 for the LMR, 2.60 for the NLR and 244 for the PLR were chosen as optimal to discriminate between survival and death by applying receiver operating curve (ROC) analysis. Kaplan-Meier survival analysis of patients with low preoperative LMR demonstrated a significant worse prognosis for DFS (p=0.004) and OS (p=0.002) than those with high preoperative LMR. The high NLR cohort had lower DFS (p=0.004) and OS (p=0.011). Marginally reduced DFS (p=0.068) and lower OS (p=0.039) were found in the high PLR cohort. On multivariate analysis, only preoperative LMR was an independent prognostic factor for both DFS (p=0.009, HR=1.639, 95% CI 1.129-2.381) and OS (p=0.004, HR=1.759, 95% CI 1.201-2.576) in ESCC patients. Conclusions: Preoperative LMR better predicts cancer survival compared with the cellular components of systemic inflammation in patients with ESCC undergoing esophagectomy.

Keywords

References

  1. Cihan YB, Arslan A, Cetindag MF, et al (2014). Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer. Asian Pac J Cancer Prev, 15, 4225-31. https://doi.org/10.7314/APJCP.2014.15.10.4225
  2. Colotta F, Allavena P, Sica A, et al (2009). Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis, 30, 1073-81. https://doi.org/10.1093/carcin/bgp127
  3. Dutta S, Crumley AB, Fullarton GM, et al (2011). Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer. World J Surg, 35, 1861-6. https://doi.org/10.1007/s00268-011-1130-7
  4. Feng JF, Huang Y, Chen QX (2014). Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol, 12, 58. https://doi.org/10.1186/1477-7819-12-58
  5. Fujiwara Y, Misawa T, Shiba H, et al (2014). Postoperative peripheral absolute blood lymphocyte-to-monocyte ratio predicts therapeutic outcome after pancreatic resection in patients with pancreatic adenocarcinoma. Anticancer Res, 34, 5163-8.
  6. Li YL, Gu KS, Pan YY, et al (2014). Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma. BMC Cancer, 14, 341. https://doi.org/10.1186/1471-2407-14-341
  7. Lin GN, Peng JW, Xiao JJ, et al (2014). Prognostic impact of circulating monocytes and lymphocyte-to-monocyte ratio on previously untreated metastatic non-small cell lung cancer patients receiving platinum-based doublet. Med Oncol, 31, 70. https://doi.org/10.1007/s12032-014-0070-0
  8. Liu J, Xie X, Zhou C, et al (2012). Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg, 41, 7-11. https://doi.org/10.1093/ejcts/ezr240
  9. Mantovani A, Allavena P, Sica A, et al (2008). Cancer-related inflammation. Nature, 454, 436-44. https://doi.org/10.1038/nature07205
  10. Mantovani A, Schioppa T, Porta C, et al (2006). Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev, 25, 315-22. https://doi.org/10.1007/s10555-006-9001-7
  11. Mlecnik B, Tosolini M, Kirilovsky A, et al (2011). Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol, 29, 610-8. https://doi.org/10.1200/JCO.2010.30.5425
  12. Ownby HE, Roi LD, Isenberg RR, et al (1983). Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer, 52, 126-30.
  13. Pennathur A, Gibson MK, Jobe BA, Luketich JD (2013). Oesophageal carcinoma. Lancet, 381, 400-12. https://doi.org/10.1016/S0140-6736(12)60643-6
  14. Porrata LF, Ristow K, Colgan JP, et al (2012). Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphoma. Haematologica, 97, 262-9. https://doi.org/10.3324/haematol.2011.050138
  15. Porrata LF, Ristow KM, Habermann TM, et al (2013). Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma. Blood Cancer J, 3, 110. https://doi.org/10.1038/bcj.2013.8
  16. Rashid F, Waraich N, Bhatti I, et al (2010). A pre-operative elevated neutrophil: lymphocyte ratio does not predict survival from oesophageal cancer resection. World J Surg Oncol, 8, 1. https://doi.org/10.1186/1477-7819-8-1
  17. Rosenberg SA (1996). The immunotherapy of solid cancers based on cloning the genes encoding tumor-rejection antigens. Annu Rev Med, 47, 481-91. https://doi.org/10.1146/annurev.med.47.1.481
  18. Sharaiha RZ, Halazun KJ, Mirza F, et al (2011). Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol, 18, 3362-9. https://doi.org/10.1245/s10434-011-1754-8
  19. Shen SL, Fu SJ, Huang XQ, et al (2014). Elevated preoperative peripheral blood monocyte count predicts poor prognosis for hepatocellular carcinoma after curative resection. BMC Cancer, 14, 744. https://doi.org/10.1186/1471-2407-14-744
  20. Shigeoka M, Urakawa N, Nakamura T, et al (2013). Tumor associated macrophage expressing CD204 is associated with tumor aggressiveness of esophageal squamous cell carcinoma. Cancer Sci, 104, 1112-9. https://doi.org/10.1111/cas.12188
  21. Stotz M, Pichler M, Absenger G, et al (2014). The preoperative lymphocyte to monocyte ratio predicts clinical outcome in patients with stage III colon cancer. Br J Cancer, 110, 435-40. https://doi.org/10.1038/bjc.2013.785
  22. Subimerb C, Pinlaor S, Lulitanond V, et al (2010). Circulating CD14(+) CD16(+) monocyte levels predict tissue invasive character of cholangiocarcinoma. Clin Exp Immunol, 161, 471-9. https://doi.org/10.1111/j.1365-2249.2010.04200.x
  23. Szkandera J, Gerger A, Liegl-Atzwanger B, et al (2014). The lymphocyte/monocyte ratio predicts poor clinical outcome and improves the predictive accuracy in patients with soft tissue sarcomas. Int J Cancer, 135, 362-70. https://doi.org/10.1002/ijc.28677
  24. Tang X (2013). Tumor-associated macrophages as potential diagnostic and prognostic biomarkers in breast cancer. Cancer Letters, 332, 3-10. https://doi.org/10.1016/j.canlet.2013.01.024
  25. Templeton AJ, Ace O, McNamara MG, et al (2014a). Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev, 23, 1204-12. https://doi.org/10.1158/1055-9965.EPI-14-0146
  26. Templeton AJ, McNamara MG, Seruga B, et al (2014b). Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst, 106, 124. https://doi.org/10.1093/jnci/dju124
  27. Tsai YD, Wang CP, Chen CY, et al (2014). Pretreatment circulating monocyte count associated with poor prognosis in patients with oral cavity cancer. Head Neck, 36, 947-53. https://doi.org/10.1002/hed.23400
  28. Ubukata H, Motohashi G, Tabuchi T, et al (2010). Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol, 102, 742-7. https://doi.org/10.1002/jso.21725
  29. Yoo EJ, Park JC, Kim EH, et al (2014). Prognostic value of neutrophil-to-lymphocyte ratio in patients treated with concurrent chemoradiotherapy for locally advanced oesophageal cancer. Dig Liver Dis, 46, 846-53. https://doi.org/10.1016/j.dld.2014.05.009
  30. Zhou X, Du Y, Xu J, et al (2014). The preoperative lymphocyte to monocyte ratio predicts clinical outcomes in patients with stage II/III gastric cancer. Tumour Biol, 35, 11659-66. https://doi.org/10.1007/s13277-014-2504-x

Cited by

  1. Association of lymphocyte-to-monocyte ratio with the no-reflow phenomenon in patients who underwent a primary percutaneous coronary intervention for ST-elevation myocardial infarction vol.26, pp.8, 2015, https://doi.org/10.1097/MCA.0000000000000301
  2. The prognostic influence of body mass index, resting energy expenditure and fasting blood glucose on postoperative patients with esophageal cancer vol.16, pp.1, 2016, https://doi.org/10.1186/s12876-016-0549-6
  3. The clinical significance of systemic inflammation score in esophageal squamous cell carcinoma vol.37, pp.3, 2016, https://doi.org/10.1007/s13277-015-4152-1
  4. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer vol.39, pp.2, 2017, https://doi.org/10.1002/hed.24576
  5. Prognostic value of parameters derived from white blood cell and differential counts in patients receiving palliative radiotherapy vol.5, pp.3, 2016, https://doi.org/10.3892/mco.2016.965
  6. Relationship between monocyte-to-lymphocyte ratio and coronary plaque vulnerability in patients with stable angina vol.11, pp.11, 2017, https://doi.org/10.2217/bmm-2017-0235
  7. High neutrophil-to-lymphocyte ratios confer poor prognoses in patients with small cell lung cancer vol.17, pp.1, 2017, https://doi.org/10.1186/s12885-017-3893-1
  8. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis vol.26, pp.4, 2017, https://doi.org/10.15570/actaapa.2017.28
  9. MiR-375 suppresses invasion and metastasis by direct targeting of SHOX2 in esophageal squamous cell carcinoma pp.1745-7270, 2017, https://doi.org/10.1093/abbs/gmw131
  10. Upregulated miR-193a-3p as an oncogene in esophageal squamous cell carcinoma regulating cellular proliferation, migration and apoptosis vol.12, pp.6, 2016, https://doi.org/10.3892/ol.2016.5229
  11. A novel marker of inflammation in patients with slow coronary flow: lymphocyte-to-monocyte ratio vol.10, pp.5, 2016, https://doi.org/10.2217/bmm-2016-0022
  12. Reference values of neutrophil-lymphocyte ratio, lymphocyte-monocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in healthy adults in South Korea vol.97, pp.26, 2018, https://doi.org/10.1097/MD.0000000000011138
  13. Prognostic role of neutrophil–lymphocyte ratio in esophageal cancer vol.97, pp.49, 2018, https://doi.org/10.1097/MD.0000000000013585